BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32020230)

  • 1. Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect?
    El-Tohamy R; Elkholi I; Elsherbiny ME; Magdy M; Hammam O; Allalunis-Turner J; Emara M
    Oncol Rep; 2020 Mar; 43(3):975-985. PubMed ID: 32020230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
    Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
    BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions.
    Huang BR; Liu YS; Lai SW; Lin HJ; Shen CK; Yang LY; Lu DY
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.
    Bache M; Rot S; Keßler J; Güttler A; Wichmann H; Greither T; Wach S; Taubert H; Söling A; Bilkenroth U; Kappler M; Vordermark D
    Oncol Rep; 2015 Jun; 33(6):3155-61. PubMed ID: 25963717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers.
    Elsherbiny ME; Shaaban M; El-Tohamy R; Elkholi IE; Hammam OA; Magdy M; Allalunis-Turner J; Emara M
    Front Oncol; 2021; 11():590771. PubMed ID: 33996536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
    BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
    Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
    Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
    Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of oxygen concentration and pH on expression of hypoxia induced genes.
    Sørensen BS; Hao J; Overgaard J; Vorum H; Honoré B; Alsner J; Horsman MR
    Radiother Oncol; 2005 Aug; 76(2):187-93. PubMed ID: 16098620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
    Mayer A; Schneider F; Vaupel P; Sommer C; Schmidberger H
    Int J Oncol; 2012 Oct; 41(4):1260-70. PubMed ID: 22825389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
    Ho KH; Shih CM; Liu AJ; Chen KC
    Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
    Wang E; Zhang C; Polavaram N; Liu F; Wu G; Schroeder MA; Lau JS; Mukhopadhyay D; Jiang SW; O'Neill BP; Datta K; Li J
    PLoS One; 2014; 9(1):e86102. PubMed ID: 24465898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL; Chu JS; Su WC; Huang SC; Lee WY
    Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells.
    Emara M; Turner AR; Allalunis-Turner J
    Int J Oncol; 2014 Feb; 44(2):514-20. PubMed ID: 24270851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.
    Kristiansen G; Rose M; Geisler C; Fritzsche FR; Gerhardt J; Lüke C; Ladhoff AM; Knüchel R; Dietel M; Moch H; Varga Z; Theurillat JP; Gorr TA; Dahl E
    Br J Cancer; 2010 Jun; 102(12):1736-45. PubMed ID: 20531416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
    Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
    Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.
    Cui J; Zhang Q; Song Q; Wang H; Dmitriev P; Sun MY; Cao X; Wang Y; Guo L; Indig IH; Rosenblum JS; Ji C; Cao D; Yang K; Gilbert MR; Yao Y; Zhuang Z
    Neuro Oncol; 2019 Nov; 21(11):1436-1446. PubMed ID: 31276594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
    BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.